Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse lung disease
Y. Sato (Yokohama, Japan), T. Baba (Yokohama, Japan), K. Higa (Yokohama, Japan), R. Ootoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), T. Oda (Yokohama, Japan), H. Kitamura (Yokohama, Japan), Y. Okudela (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Ogura (Yokohama, Japan)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Sato (Yokohama, Japan), T. Baba (Yokohama, Japan), K. Higa (Yokohama, Japan), R. Ootoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), T. Oda (Yokohama, Japan), H. Kitamura (Yokohama, Japan), Y. Okudela (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Ogura (Yokohama, Japan). Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse lung disease. 745
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: